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Available online 12 September 2012AbstractAim: The present study was designed to investigate the preventive effect of luteolin on lipid peroxidation, antioxidants and histopathological
findings in acute and chronic periods after isoproterenol (ISO)-induced myocardial-infarction (MI) in male Wistar rats.
Methods: Luteolin supplemented by intragastric intubation at a daily dose of 0.3 mg/kg body weight in acute and chronic periods following MI.
In acute MI model, luteolin had been administered once per day to rat groups during 30 days. On days 29 and 30th the rats of the acute MI
control groups were administered 85mg/kg body weight, isoproterenol, intraperitoneally intravel of 24h. In chronic MI model luteolin
administered of rat group during 30 days, and on the 1st and 2nd days, the rats of the chronic MI control and luteolin treatment groups were
administered ISO by the same way.
Results: The ISO-induced rats both in acute and chronic models showed significant increase in the levels of thiobarbituric acid reactive
substances, lipid hydroperoxides in the heart and erythrocyte, and significant decrease in the activities of heart and erythrocytes superoxide
dismutase, catalase, glutathione peroxidase, reduced glutathione. Oral treatment with luteolin at a daily dose of (0.3 mg/kg b.wt) in both acute
and chronic models showed significant decrease in the levels of heart and erythrocyte lipid peroxidation by products and significant increase in
the levels of antioxidant system. The protective role of luteolin (0.3 mg/kg b.wt) on ISO-induced myocardial infarction was further confirmed by
histopathological examination.
Conclusion: Thus, the experiment clearly showed that luteolin ameliorates cardiac damage in ISO-induced myocardial infarction by prevented
the accumulation of lipids due to the anti-lipid peroxidative effect.
Copyright  2012, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Myocardial infarction (MI) continues to be a major public
health problem, not only in Western countries but also
increasingly in developing countries and makes a significant
contribution to the mortality statistics.1 In India, the number of
patients being hospitalized for myocardial infarction,
commonly known as heart attack, is increasing over the past* Corresponding author. Department of Biochemistry, Periyar University,
Periyar Palkalainagar, Salem 636 011, Tamil Nadu, India.
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http://dx.doi.org/10.1016/j.jacme.2012.06.00135 years and male patients have shown a more striking
increase.2 MI is the acute condition of necrosis of the
myocardium that occurs as a result of critical imbalance
between coronary blood supply and myocardial demand.3
Isoproterenol, a synthetic catecholamine and b-adrenergic
agonist is a well known inducer of myocardial hypertrophy has
been reported to cause severe stress in the myocardium
resulting in infarct like necrosis of the heart muscles.4 It is also
well known to generate free radicals and stimulate lipid per-
oxidation, which may be a causative factor in irreversible
damage to the myocardial membrane.5 By studying the
biochemical alterations that take place in an animal model, itMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
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the altered metabolic process in human myocardial infarction.6
The flavonoids appear to have played a major role in the
successful medical treatments and their use has persevered up
to now. Flavonoids are widely distributed polyphenol
compounds in the plant kingdom and constitute an important
source of natural products which plays an important role in the
development of various human diseases including cardiovas-
cular diseases.
Luteolin, 30, 40, 5, 7-tetrahydroxyflavone (Fig. 1), is
a polyphenolic compound is widely distributed in fruits, herbs
and green vegetables such as artichoke, celery, peppermint,
broccoli, cauliflower, green pepper, perilla leaf, camomile tea,
cabbage, thyme, honeysuckle and spinach.7,8 Several epide-
miological studies have shown that high consumption of foods
containing luteolin is associated with a reduced risk of
developing chronic diseases.9 Numerous experimental data
have revealed that luteolin possesses a wide range of phar-
macological effects, including antioxidant,10 anti-neoplastic,11
anti-hepatotoxic, anti-allergic, anti-osteoporotic,12 anti-dia-
betic,13 anti-inflammatory,14 anti-platelet and vasodilatory
activity.15 But till now there are no studies related to the effect
of luteolin against isoproterenol induced myocardial infarction
in rats. So we made an attempt to study the protective role of
luteolin in ISO-induced cardiac damage with reference to lipid
peroxidation and antioxidants that play an important role in
cardiac damage.2. Materials and methods2.1. ChemicalsIsoproterenol, luteolin were purchased from the Sigma
Chemical Co. (St. Louis, MO, USA). All the other chemicals
and reagents used were of analytical grade.2.2. Formulation and administration of luteolinLuteolin powder was suspended in 0.5% carboxymethyl
cellulose (CMC) and each animal belonging to three different
groups received 1.0 ml of luteolin suspension at a dose of
0.3 mg/kg body weight everyday respectively by intragastric
intubation.10Fig. 1. Structure of luteolin and its molecular formula C15H10O6, molecular
weight 286.924.2.3. Induction of myocardial infarction
2.3.1. Acute myocardial infarction (AMI)
The acute myocardial infarction was induced by intra-
peritoneal (i.p.) injection of isoproterenol hydrochloride
(85 mg/kg body weight, dissolved in physiological saline, for
29th and 30th days.16
2.3.2. Chronic myocardial infarction (CMI)
The Chronic myocardial infarction was induced by intra-
peritoneal (i.p.) injection of isoproterenol hydrochloride
(85 mg/kg body weight, dissolved in physiological saline, for
1st and 2nd days.162.4. Animal housing and dietsMale Wistar albino rats aged 6 weeks and weighing about
150 g were obtained from Sri Venkateshwara enterprises
Bangalore, India. After one week of acclimatization all
animals were housed six per polypropylene plastic cage
covered with metal grids and a hygienic bed of husk in
a specific-pathogen free animal room under controlled
conditions of a 12 h light/12 hour dark cycle, and provided
with standard food pellets (diet composition, wheat broken-
moisture 9.0%, crude protein, 11.5% crude fat, 1.9% crude
fibre 4% ash 0.2%, nitrogen-free extract 73.4%) supplied by
Hindustan Lever Ltd, Mumbai, India) and tap water ad
libitum. The study was conducted after obtaining a clearance
from the institutional animal ethical committee (IAEC) (Reg
.no P.Col/52/2010/IAEC/VMCP) of Vinayaka Mission
College of Pharmacy, Salem, Tamil Nadu.2.5. Study design and treatment scheduleIn the experiment, the total of 36 rats (24 myocardial rats,
12 normal rats) were used. The rats were randomly assigned
into six groups of 6 animals each. Total duration of the
experiment was 30 days.
The rats in group I received 1.0 ml of 0.5% CMC every day
via intragastric intubation and served as the untreated control.
The rats in group II received luteolin via intragastric intubation
at a daily dose of (0.3 mg/kg body weight) respectively for
a period of 30 days. Group III rats received isoproterenol
(85 mg/kg body weight) intraperitoneally twice at an interval
of 24 h on the 29th and 30th days (Acute myocardial infarc-
tion). Group IV rats received isoproterenol (85 mg/kg body
weight) intraperitoneally twice at an interval of 24 h on the 1st
and 2nd days (Chronic myocardial infarction). Group V rats
received luteolin as in group II for 30 days and at the last of
the experimental period on 29th and 30th days rats received
isoproterenol (85 mg/kg body weight) injections intraperito-
neally twice at an intravel of 24 h (Acute myocardial
infarction þ Luteolin). Group VI rats received isoproterenol as
in group IV for 2 days and at the of the experimental period
rats received luteolin (0.3 mg/kg body weight) (Chronic
myocardial infarction þ Luteolin).
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by cervical decapitation. The blood was collected and serum
obtained after centrifugation were used for various biochem-
ical estimations. Heart were removed, cleared of blood and
immediately transferred to ice cold containers containing 0.9%
sodium chloride. Samples of tissues were homogenized in
appropriate buffer and used for the determination of the
following parameters.2.6. Biochemical estimationsLipid peroxidation was estimated by measuring the level
of thiobarbituric acid reactive substances (TBARS) in tissues
via the method of Niehaus and Samuelson17 and plasma or
erythrocyte via the method of Yagi.18 The pink chromogen
produced by the reaction of thiobarbituric acid with malon-
dialdehyde, a secondary product of lipid peroxidation, was
measured at 532 nm. The values are expressed as nmoles/
100 g tissue or nmoles/mg Hb. Reduced glutathione (GSH)
content was determined via the method of Moron et al.19
GSH determination is based on the development of yellow
colour when 5, 50 dithio 2-nitro benzoic acid (DTNB) is
added to compounds containing sulfhydryl groups. The
values are expressed as nmoles g-1 wet tissue. Glutathione
peroxidase (GPx EC.1.11.1.9) activity was assayed via the
method of Rotruck20 with a modification: a known amount of
enzyme preparation was incubated with H2O2 in the presence
of GSH for a specified time period. The amount of H2O2
utilized was determined via the method of Habig et al.21 The
values are expressed as mmoles of GSH utilized/min/mg Hb
or protein. Superoxide dismutase (SOD EC.1.15.1.1) was
assayed using the method of Marklund and Marklund22 based
on the 50% inhibition of the formation of NADH- phenazine
methosulfate-nitroblue tetrazolium formazan at 520 nm. One
unit of the enzymes is taken as the amount of enzyme for
50% inhibition of NBT reduction/min/mg protein. The
activity of catalase (CAT EC. 1.11.16) was determined via
the method of Sinha23: dichromate in acetic acid was reduced
to chromic acetate when heated in the presence of hydrogen
peroxide (H2O2), with the formation of perchromic acid as an
unstable CAT intermediate. The chromic acetate formed was
measured at 590 nm. Catalase was allowed to split H2O2 for
different periods of time. The reaction was stopped at
different time intervals via the addition of a dichromate
acetic acid mixture, and heating the reaction mixture and
measuring chromic acetate colorimetrically and determined
the remaining H2O2.2.7. Preparation of hemolysateBlood was collected in heparinized tubes and plasma was
separated by centrifugation at 2000g for 10 min. After the
separation of plasma, the buffy coat was removed and packed
cells (RBCs) were washed thrice with cold physiological
saline. To determine the activity of RBC antioxidant
enzymes, RBC lysate was prepared by lysing a known
volume of RBCs with hypotonic phosphate buffer, pH 7.4and centrifuged at 3000g for 10 min at 2C to separate the
hemolysate.2.8. Preparation of tissue homogenateHeart tissue was removed immediately and washed with
ice-cold saline and homogenized in the appropriate buffer in
a tissue homogenizer.2.9. Histopathological studiesAt the end of the study, all the rats were sacrificed by
cervical decapitation and the hearts were dissected out,
washed in ice cold saline. Then myocardial tissue was
immediately fixed in 10% buffered neutral formalin solution.
After fixation, tissues were embedded in paraffin and serial
sections were cut and each section was stained with hema-
toxylin and eosin. The slides were examined under a light
microscope and photographs were taken.
2.9.1. Statistical analysis
The results presented here are the means  SD of 6 rats in
each group. The results were analyzed using one-way analysis
of variance [ANOVA] and the group means were compared
using Duncan’s multiple range test [DMRT] using SPSS
version 12 for Windows. The findings were considered as
statistically significant if P < 0.05.24
3. Results3.1. Histopathological observationsNormal architecture of the cardiac cells was observed with
no evidence of microscopic changes in the control and luteolin
treated groups (Fig. 2). In isoproterenol (85 mg/kg body
weight) treated rats’ heart showing focal confluent necrosis of
muscle fiber with inflammatory cell infiltration, edema with
fibroblastic proliferation and phagocytosis were seen. In
luteolin (0.3 mg/kg body weight) and isoproterenol (85 mg/kg
body weight) treated rats, showing mild degree of necrosis and
less infiltration of inflammatory cells.3.2. Effect of luteolin on lipid peroxidation in the
myocardial infarction ratsTable 1 depicts the effect of luteolin on circulatory and
tissue levels of TBARS in the control and experimental rats.
The levels of plasma, erythrocyte and tissue TBARS was
significantly (P < 0.05) increased in the acute and chronic
periods of ISO-induced rats (groups 3 and 4) as compared to
the control rats (group 1). However, pre-treatment with
luteolin reduced TBARS levels to normal levels. Luteolin
administration to isoproterenol treated rats (groups 5 and 6)
significantly (P < 0.05) decreased in the levels of TBARS
tissue erythrocyte and serum as compared with acute and
chronic periods of ISO-induced rats (groups 3 and 4).
Fig. 2. Histopathology changes in the myocardial infarction of control and experimental rats. Effect of luteolin on isoproterenol induced myocardial infarction in
rats. A) Normal control heart showing normal cardiac muscle fibers. B) Group II (luteolin) heart showed no changes. C) Group III (AMI) ISO (85 mg/kg twice with
a duration of 24 h) control heart showing focal confluent necrosis of muscle fiber with inflammatory cell infiltration, edema with fibroblastic proliferation and
phagocytosis along extravasation of red blood cells. D) Group IV (CMI) ISO (85 mg/kg twice with a duration of 24 h) control heart showing cardiac muscle fibers
with muscle separation and inflammatory collections, cardiac necrosis and splitting of muscle bundles. E) Group V (AMIþluteolin) rats showing mild degree of
necrosis and less infiltration of inflammatory cells; F) Group VI (CMIþluteolin) showing some cardiac muscle cell denaturation alone with infiltration of a small
amount of inflammatory cells could be observed, necrosis was not obvious.
Table 1
Effect of luteolin on circulating and tissue lipid peroxidation (TBARS) of control and experimental rats.
Groups Control Luteolin
(0.3 mg/kg b.wt)
Acute MI
(85 mg/kg b.wt)
Chronic MI
(85 mg/kg b.wt)
Luteolin þ
Acute MI
Luteolin þ
Chronic MI
Plasma thiobarbituric acid
reactive substances (nM/ml)
3.01  0.16 1.9  0.26 3.4  0.20a 4.0  0.19a 3.3  0.16b 3.6  0.21b
Heart tissue thiobarbituric
acid reactive substances
(mM/100 g wet tissue)
37.74  0.05 33.16  0.35 110  0.35a 114  0.27a 85.7  0.32b 90.12  0.32b
Erythrocyte thiobarbituric acid
reactive substances (nmoles
MDA released min-1 mg-1 protein)
1.7  0.14 1.2  0.24 3.1  0.19a 3.5  0.19a 2.3  0.26b 2.9  0.26b
The results are expressed as mean  SD of six rats in each group.
a P < 0.05 when compared with normal.
b P < 0.05 when compared with isoproterenol.
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Table 2
Effect of luteolin on circulatory antioxidants of control and experimental rats.
Groups Control Luteolin Acute MI
(85 mg/kg b.wt)
Chronic MI
(85 mg/kg b.wt)
Luteolin þ
Acute MI
Luteolin þ
Chronic MI
Circulatory antioxidants
Superoxide dismutase (SOD) (IU/L) 7.8  0.34 8.2  0.25 3.3  0.39a 3.1  0.29a 6.05  0.42b 6.3  0.39b
Catalase (CAT) (IU/L) 21  1.80 25  1.02 13  0.29a 11  0.54a 14  0.56b 17  0.29b
Glutathione peroxidase (GPx) (IU/L) 0.33  0.03 0.48  0.03 0.20  0.02a 0.16  0.02a 0.28  0.02b 0.29  0.02b
Glutathione reductase (IU/L) 1.8  0.58 2.2  0.15 1.3  0.23a 1.1  0.13a 1.5  0.11b 1.65  0.22b
The results are expressed as mean  SD of ten rats in each group.
a p < 0.05 when compared with normal.
b p < 0.05 when compared with isoproterenol.
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myocardial infarction ratsTable 2 illustrates the effect of luteolin on circulatory anti-
oxidants (SOD, CAT, GSH and GPx) in the control and exper-
imental rats. The circulating levels of (SOD, CAT, GSH and
GPx) were significantly (P < 0.05) decreased in the acute and
chronic periods of ISO-induced rats (groups 3 and 4) as
compared to the control rats (group 1). However, pre-treatment
with luteolin (group 2) increased the circulatory antioxidants
near to normal levels. Luteolin administration to acute and
chronic periods of ISO-induced rats (groups 5 and 6) was
significantly (P < 0.05) increased the levels of antioxidants
(SOD, CAT, GSH andGPx) as compared to the unsupplemented
acute and chronic periods of ISO-induced rats (groups 3 and 4).3.4. Effect of luteolin on tissue antioxidants in the
myocardial infarction ratsTable 3 depicts the effect of luteolin on heart tissue anti-
oxidants (SOD, CAT, GSH and GPx) of control and experi-
mental rats. The tissue antioxidant levels (SOD, CAT, GSH
and GPx) were significantly (P < 0.05) decreased in acute and
chronic periods of ISO-induced rats (groups 3 and 4) as
compared to the control rats (group 1). However, pre-treatment
with luteolin (group 2) increased the circulatory antioxidants
near to normal levels. Luteolin administration to acute and
chronic periods of ISO-induced rats (groups 5 and 6) wereTable 3
Effect of luteolin on tissue antioxidants of control and experimental rats.
Groups Control Luteolin
Tissue antioxidants
Superoxide dismutase (SOD) (U/mg protein) 13.5  0.19 16.8  0.24
Catalase (CAT) (mmoles of H202
consumed/min/mg protein)
7.69  0.38 8.22  0.51
Glutathione peroxidase (GPx)
(mg of GSH consumed/min/mg protein)
5.18  1.11 6.36  1.34
Glutathione reductase (nmoles of
NADPH oxidised/min/100 mg protein)
7.98  0.18 9.01  0.19
Glutathione-S-transferase (nmoles of CDNB
conjucated/min/mg protein)
795.21  58.8 822.6  56.5
The results are expressed as mean  SD of ten rats in each group.
a p < 0.05 when compared with normal.
b p < 0.05 when compared with isoproterenol.significantly (P < 0.05) increased the levels of tissue antiox-
idants (SOD, CAT, GSH and GPx) as compared to the
unsupplemented acute and chronic periods ISO-induced rats
(groups 3 and 4).
4. Discussion
Epidemiological studies indicate that IHD, especially MI,
will contribute to the major disease burden worldwide in the
year 2020 and in fact, MI is considered the most leading cause
of death worldwide even with the huge improvement in clin-
ical care and the wide use of various health care innovations.25
Myocardial infarction is characterized by cardiac dysfunction,
increased lipid peroxidation, altered activities of cardiac injury
markers and depletion of endogenous antioxidants.26e28
Lipid peroxidation, is a type of free radical-mediated prop-
agation of oxidative insult to polyunsaturated fatty acid (PUFA)
involving several types of free radicals and termination occurs
through enzymatic means or scavenging of free radical by
antioxidants.29 It is an important pathogenic event inmyocardial
necrosis and accumulation of lipid hydroperoxides reflects the
damage of the cardiac constituents.30 In the present study we
observed the increased levels of lipid peroxidation (TBARS) in
serum, erythrocyte and heart tissue of acute and chronic periods
after ISO-induced rats (Groups 3 and 4) when compared to
control rats, which may lead to the lipid peroxidation products
injure blood vessels, causing increased adherence and aggre-
gation of platelets to the injured site,31 and it could attribute toAcute MI
(85 mg/kg b.wt)
Chronic MI
(85 mg/kg b.wt)
Luteolin þ
Acute MI
Luteolin þ
Chronic MI
10.9  0.34a 10.4  0.23a 11.8  0.25b 11.2  0.34b
3.61  0.17a 3.36  0.26a 6.11  0.45b 5.62  0.17b
2.08  1.32a 1.88  1.6a 3.68  1.72b 3.48  1.42b
4.94  0.22a 4.64  0.22a 6.95  0.17b 6.14  0.28b
554.6  36.1a 534.3  35.2a 688.1  49.4b 665.6  53.1b
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observed during myocardial infarction.32
The decreased level of TBARS in luteolin pretreated rats
(group 4) when compared to control (Group 1) and isopro-
terenol induced rats (Groups 3 and 4). This might be due to
enhanced activities of antioxidant enzymes. Luteolin has
shown to efficiently scavenge hydroxyl and peroxyl radicals
and contributes to the defense against lipid peroxidation.33
The free radical scavenging and anti-lipidperoxidative
activity of luteolin revealed in heart supports the earlier
reports, demonstrated the protective effect of luteolin against
oxidative damages of the organs including heart.33
The formation of free radicals and accumulation of lipid
peroxides is one of the possible biochemical mechanisms for
the myocardial damage caused by this catecholamine.34
Antioxidants constitute the foremost defense system that
limits the toxicity associated with free radicals. Hence, these
antioxidants are expected to be consumed by enhanced radical
reactions.35 Free radical scavenging enzymes such as catalase,
superoxide dismutase, glutathione peroxidase are the first line
cellular defense against oxidative injury,36 decomposing O2
and H2O2 before their interaction to form the more reactive
hydroxyl radical (OH). The equilibrium between these
enzymes is essential for the effective removal of oxygen stress
in intracellular organelles. However, in pathological condi-
tions like MI, the generation of ROS can dramatically upset
this balance with an increased demand on the antioxidant
defense system.
SOD and CAT are anti-peroxidative enzymes that protect
the cellular constituents against oxidative damage. SOD and
CAT are two important enzymatic antioxidants that act against
toxic oxygen free radicals such as superoxide (O2
- ) and
hydroxyl ($OH ) ions in the biological system. They are
involved in the direct elimination of reactive oxygen metab-
olites, which is probably one of the most effective defenses of
the living body against diseases. In the present study there is
decreased levels of SOD and CAT in the heart tissue and
serum as observed at acute and chronic periods ISO-induced
rats (Groups 3 and 4). This may be due to increased produc-
tion of reactive oxygen radicals which are capable of reducing
the activities of these enzymes37 and it’s loss of function and
integrity of the myocardial membrane, which is usually
observed during myocardial necrosis.31 This can leads to the
accumulation of superoxide anion which further damages the
myocardium.38 It may also due to an excessive formation of
superoxide anions. A decrease in SOD activity can result in
the decreased removal of superoxide anions which can be
harmful to the myocardium.39 The activities of H2O2 scav-
enging enzymes CAT and GPx were also decreased signifi-
cantly. The decline in these enzyme levels may be explained
by the fact that excessive superoxide anions may inactivate
SOD, thus, resulting in an inactivation of the H2O2 scavenging
enzymes.
Luteolin pre-treatment (Group 2) prevented decline of the
myocardial SOD and CAT activities when compared to
control group I and ISO-induction rats (Groups 3 and 4).
Present findings are also strongly supportive of itsantioxidant activity against ISO-induced oxidative stress.
Luteolin was reported to scavenge superoxide radicals and
hydrogen peroxide. Because of these activities, it was ex-
pected that luteolin could decrease the workload of SOD,
CAT and reduce the free radical mediated inactivation of
enzymes and thereby maintaining the activities of enzymatic
antioxidants.
Glutathione (GSH) is important in protecting the
myocardium against free radical mediated injury and thus
a reduction in the cellular GSH content could impair
recovery after short period of ischemia.40 In the present study
it was observed that acute and chronic periods of ISO-
induction rats (groups 3 and 4) showed a significant
decrease in myocardial GSH and GPx activity it may be due
to the increased oxidative stress. Glutathione has the ability
to manage oxidative stress with adaptional changes in
enzymes regulating its metabolism.41 Increased concentra-
tions of reactive oxygen species have been implicated in the
development of cardiac diseases.42
Luteolin pre-treatment (Group 2) prevented decline of the
myocardial GPx and GSH activities in acute and chronic
periods of ISO-induction rats (Groups 3 and 4). Present study
findings also strongly supportive of its antioxidant activity
against ISO-induced oxidative stress.
Decreased activities of GPx and GSH may be due to loss
of enzymes after cell membrane disruption by the events of
lipid peroxidation. GPx, GSH are ‘SH’ dependent enzymes,
and their ‘SH’ groups can react with ISO oxidation products,
quinones and isoprenochrome, leading to enzyme inactiva-
tion. The inhibition of these enzymes not only reflects
oxidative stress, but also exposes the cells to further oxida-
tive damage, since GPx and GSH are essential enzymes in
cellular protection against ROS. Luteoiln administration
changes the levels of GPx and GSH by restoring reduced
glutathione level and counteracting the free radicals
produced by ISO.
5. Conclusion
In our experiment, we found that luteolin protected
myocardium from isoproterenol-induced myocardial func-
tional and structural injury via favourably improved hemo-
dynamic, biochemical, histopathological and biochemical
parameters suggesting its cardioprotective action.
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